These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 19475873)

  • 1. [The BEAUTIFUL study].
    Gensini GF; Lanza GA
    G Ital Cardiol (Rome); 2009 Apr; 10(4):203-8. PubMed ID: 19475873
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of a pure reduction in heart rate for the treatment of left ventricular dysfunction: clinical benefits of ivabradine in the BEAUTIFUL trial.
    Danchin N
    Therapie; 2009; 64(2):111-4. PubMed ID: 19664404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BEAUTIFUL results--the slower, the better?
    Reil JC; Böhm M
    Lancet; 2008 Sep; 372(9641):779-80. PubMed ID: 18757092
    [No Abstract]   [Full Text] [Related]  

  • 4. Interpreting clinical trials: the 'beautiful' case.
    Agewall S; Atar D
    Fundam Clin Pharmacol; 2009 Apr; 23(2):261-2. PubMed ID: 19236485
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevated heart rate proven to increase coronary events.
    Fox K; Steg PG
    Cardiovasc J Afr; 2008; 19(5):276-8. PubMed ID: 18997992
    [No Abstract]   [Full Text] [Related]  

  • 6. Lessons from the BEAUTIfUL trial.
    Cardiovasc J Afr; 2009; 20(4):261-2. PubMed ID: 19701541
    [No Abstract]   [Full Text] [Related]  

  • 7. [SIGNIFY study is a disappointment. Ivabradine cannot stop of the progression of coronary heart disease].
    Einecke D
    MMW Fortschr Med; 2014 Sep; 156(15):1. PubMed ID: 25282913
    [No Abstract]   [Full Text] [Related]  

  • 8. [New study on surgery in coronary disease and heart failure. Of what value is left ventricular reconstruction in addition to coronary surgery?].
    Sartipy U; Lindblom D
    Lakartidningen; 2009 Sep 30-Oct 6; 106(40):2522, 2524. PubMed ID: 19908621
    [No Abstract]   [Full Text] [Related]  

  • 9. Invited commentary.
    Thomas SP
    Ann Thorac Surg; 2009 Sep; 88(3):807-8. PubMed ID: 19699902
    [No Abstract]   [Full Text] [Related]  

  • 10. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of myofilament dysfunction by beta-blocker therapy in postinfarct remodeling.
    Duncker DJ; Boontje NM; Merkus D; Versteilen A; Krysiak J; Mearini G; El-Armouche A; de Beer VJ; Lamers JM; Carrier L; Walker LA; Linke WA; Stienen GJ; van der Velden J
    Circ Heart Fail; 2009 May; 2(3):233-42. PubMed ID: 19808345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial.
    Daubert C; Gold MR; Abraham WT; Ghio S; Hassager C; Goode G; Szili-Török T; Linde C;
    J Am Coll Cardiol; 2009 Nov; 54(20):1837-46. PubMed ID: 19800193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers in the treatment of aortic regurgitation a new opportunity?
    Elkayam U
    J Am Coll Cardiol; 2009 Jul; 54(5):458-9. PubMed ID: 19628122
    [No Abstract]   [Full Text] [Related]  

  • 14. Surgical ventricular reconstruction.
    Hu S; Zheng Z; Fan H
    N Engl J Med; 2009 Jul; 361(5):529; author reply 531-2. PubMed ID: 19645079
    [No Abstract]   [Full Text] [Related]  

  • 15. The STICH trial: misguided conclusions.
    Buckberg GD; Athanasuleas CL
    J Thorac Cardiovasc Surg; 2009 Nov; 138(5):1060-1064.e2. PubMed ID: 19837213
    [No Abstract]   [Full Text] [Related]  

  • 16. Surgical left ventricular remodeling leads to better long-term survival and exercise tolerance than coronary artery bypass grafting alone in patients with moderate ischemic cardiomyopathy.
    Dzemali O; Risteski P; Bakhtiary F; Singer E; Zierer A; Kleine P; Moritz A
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):663-8. PubMed ID: 19698853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poor left ventricular function is not a contraindication for robotic totally endoscopic coronary artery bypass grafting.
    Rehman A; Garcia J; Deshpande S; Fitzpatrick M; Odonkor P; Zimrin D; Griffith B; Bonatti J
    Heart Surg Forum; 2009 Jun; 12(3):E152-4. PubMed ID: 19546067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heart rate reduction for 12 months with ivabradine reduces left ventricular mass in cardiac allograft recipients.
    Doesch AO; Ammon K; Konstandin M; Celik S; Kristen A; Frankenstein L; Buss S; Hardt S; Sack FU; Katus HA; Dengler TJ
    Transplantation; 2009 Sep; 88(6):835-41. PubMed ID: 19920784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic factors affecting the all-cause death and sudden cardiac death rates of post myocardial infarction patients with low left ventricular ejection fraction.
    Dai SM; Zhang S; Chen KP; Hua W; Wang FZ; Chen X
    Chin Med J (Engl); 2009 Apr; 122(7):802-6. PubMed ID: 19493393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lowering interleukin-1 activity with anakinra improves myocardial deformation in rheumatoid arthritis.
    Ikonomidis I; Tzortzis S; Lekakis J; Paraskevaidis I; Andreadou I; Nikolaou M; Kaplanoglou T; Katsimbri P; Skarantavos G; Soucacos P; Kremastinos DT
    Heart; 2009 Sep; 95(18):1502-7. PubMed ID: 19482847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.